Skip to main content
Caplight Logo









Lysando AG

Lysando AG

Private
TriesenbergHealthcare & Life Scienceshttps://lysando.com/en/

Last Round

Strategic

Aug 2, 2021

Est. Valuation

$356.1M

Company Overview

Lysando AG is a biotechnology company that provides research and development services for antimicrobial proteins, called Artilysin®s, intended to combat pathogenic and antibiotic-resistant bacteria.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

antibiotic alternativeArtilysinantimicrobial proteinsantimicrobial resistanceAMRtechnology licensingbiotechnology platformphage lysinsendolysinsprotein engineeringsuperbugsmulti-drug resistancebacterial lysiswound careveterinary medicineAI protein design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lysando AG Comparables

Compare Lysando AG with similar companies based on industry and business-model similarity.

Lysando AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Micreos Group
76%
GangaGen
74%
Telum Therapeutics
73%
View all Comparables

Lysando AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicAug 2, 2021
Corporate FundingNov 12, 2014
View all Funding Rounds

Lysando AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lysando AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lysando AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersTriesenberg
Year Founded2009
Last FundingAug 2, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?